<div id="readability-page-1"><p>In a report released today, Julian Harrison from BTIG reiterated a Buy rating on Cullinan Management, with a price target of <span id="expert-recommendation-target">$38.00</span>.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Harrison covers the Healthcare sector, focusing on stocks such as Cullinan Management, Oruka Therapeutics, and Nektar Therapeutics. According to TipRanks, Harrison has an average return of <span>37.8%</span> and a 57.61% success rate on recommended stocks. </p> <p>In a report released today, Morgan Stanley also maintained a Buy rating on the stock with a $28.00 price target.</p></div>

CGEM

<p>BTIG's Julian Harrison reiterated a Buy rating for Cullinan Management (CGEM) with a $38 price target. Morgan Stanley also maintained a Buy rating with a $28 target. Harrison, focusing on healthcare stocks, has a 37.8% average return and a 57.61% success rate. TipRanks offers a Cyber Monday sale for its Premium insights and tools.</p>

Cullinan Management (CGEM) Gets a Buy from BTIG